Recent News

• 11.18.2025 - Tactile Medical to Present at the Piper Sandler 37th Annual Healthcare Conference
• 11.13.2025 - Breast cancer-related lymphedema video resources
• 11.03.2025 - Tactile Systems Technology, Inc. Reports Third Quarter 2025 Financial Results
• 10.28.2025 - Landmark Study Demonstrates Sustained Clinical Benefits of Flexitouch® Plus as First-Line Therapy in Treating Head and Neck Cancer-Related Lymphedema
• 10.21.2025 - Peripheral Edema
• 10.21.2025 - Inflammation vs Swelling
• 10.21.2025 - Lymphedema and Weight Loss
• 10.20.2025 - Tactile Medical to Release Third Quarter of Fiscal Year 2025 Financial Results on November 3, 2025
• 10.16.2025 - Chronic Venous Insufficiency
• 08.04.2025 - Q2 2025 Tactile Medical Earnings Conference Call

Recent Filings

• 11.03.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 11.03.2025 - 8-K Current report
• 11.03.2025 - EX-99.1 EX-99.1
• 10.31.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 08.12.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.08.2025 - 144 Report of proposed sale of securities
• 08.07.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors